144 related articles for article (PubMed ID: 38063869)
21. Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder.
Zhang X; Ma L; Liang D; Song B; Chen J; Huang Y; Xu L; Zhao P; Wu W; Zhang N; Xue R
J Parkinsons Dis; 2023; 13(4):485-499. PubMed ID: 37182898
[TBL] [Abstract][Full Text] [Related]
22. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X
J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152
[TBL] [Abstract][Full Text] [Related]
23. Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity.
Huang Y; Huang C; Zhang Q; Shen T; Sun J
BMC Neurol; 2022 Jan; 22(1):39. PubMed ID: 35086487
[TBL] [Abstract][Full Text] [Related]
24. Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease.
Gibson LL; Pollak TA; Heslegrave A; Hye A; Batzu L; Rota S; Trivedi D; Nicholson TR; Ffytche D; Zetterberg H; Chaudhuri KR; Aarsland D
J Parkinsons Dis; 2022; 12(5):1527-1538. PubMed ID: 35466956
[TBL] [Abstract][Full Text] [Related]
25. A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes.
Li Q; Li Z; Han X; Shen X; Wang F; Bai L; Li Z; Zhang R; Wang Y; Zhu X
Front Neurosci; 2022; 16():805953. PubMed ID: 35250451
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study.
Peng L; Wan L; Liu M; Long Z; Chen D; Yuan X; Tang Z; Fu Y; Zhu S; Lei L; Wang C; Peng H; Shi Y; He L; Yuan H; Wan N; Hou X; Xia K; Li J; Chen C; Qiu R; Tang B; Chen Z; Jiang H
J Neurol; 2023 Sep; 270(9):4248-4261. PubMed ID: 37184660
[TBL] [Abstract][Full Text] [Related]
27. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.
Lin YS; Lee WJ; Wang SJ; Fuh JL
Sci Rep; 2018 Nov; 8(1):17368. PubMed ID: 30478269
[TBL] [Abstract][Full Text] [Related]
28. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
29. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
30. Blood neurofilament light chain in Parkinson's disease.
Buhmann C; Magnus T; Choe CU
J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597
[TBL] [Abstract][Full Text] [Related]
31. Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson's disease.
Batzu L; Rota S; Hye A; Heslegrave A; Trivedi D; Gibson LL; Farrell C; Zinzalias P; Rizos A; Zetterberg H; Chaudhuri KR; Aarsland D
NPJ Parkinsons Dis; 2022 Nov; 8(1):154. PubMed ID: 36371469
[TBL] [Abstract][Full Text] [Related]
32. Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.
Yang D; Xie H; Wu S; Ying C; Chen Y; Ge Y; Yao R; Li K; Jiang Z; Chen G
NPJ Parkinsons Dis; 2023 Sep; 9(1):132. PubMed ID: 37699957
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Evolution and Plasma Biomarkers for Excessive Daytime Sleepiness in Parkinson's Disease.
Lin J; Li C; Ou R; Hou Y; Zhang L; Wei Q; Liu K; Jiang Q; Yang T; Xiao Y; Pang D; Yu Y; Song W; Zhao B; Chen X; Yang J; Wu Y; Shang H
J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38526870
[TBL] [Abstract][Full Text] [Related]
34. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
35. Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
Ren J; Pan C; Wang Y; Xue C; Lin H; Xu J; Wang H; Zhang W; Xu P; Chen Y; Liu W
J Neurochem; 2022 Jun; 161(6):506-515. PubMed ID: 35234288
[TBL] [Abstract][Full Text] [Related]
36. Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study.
Mazzeo S; Ingannato A; Giacomucci G; Manganelli A; Moschini V; Balestrini J; Cavaliere A; Morinelli C; Galdo G; Emiliani F; Piazzesi D; Crucitti C; Frigerio D; Polito C; Berti V; Bagnoli S; Padiglioni S; Sorbi S; Nacmias B; Bessi V
Eur J Neurol; 2024 Jan; 31(1):e16089. PubMed ID: 37797300
[TBL] [Abstract][Full Text] [Related]
37. Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson's disease in the MARK-PD study.
Pötter-Nerger M; Dutke J; Lezius S; Buhmann C; Schulz R; Gerloff C; Kuhle J; Choe CU
J Neural Transm (Vienna); 2022 Mar; 129(3):295-300. PubMed ID: 35072765
[TBL] [Abstract][Full Text] [Related]
38. Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson's disease.
Yin W; Zhu Y; Yang B; Wang F; Yin K; Zhou C; Ren H; Yang X
Neurol Sci; 2022 Apr; 43(4):2839-2843. PubMed ID: 35088243
[TBL] [Abstract][Full Text] [Related]
39. Associations of sleep disorders with serum neurofilament light chain levels in Parkinson's disease.
Qi WY; Sun Y; Guo Y; Tan L
BMC Neurol; 2024 May; 24(1):147. PubMed ID: 38693483
[TBL] [Abstract][Full Text] [Related]
40. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
